683 Capital Management
Overview
683 Capital Management is a New York-based hedge fund manager that pursues an opportunistic, value-oriented investment strategy, utilizing both long and short positions across various asset classes.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Amylyx Pharmaceuticals | Jul 2021 | Series C | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is 683 Capital Management based?
683 Capital Management is headquartered in New York City, New York, United States.
When was 683 Capital Management founded?
683 Capital Management was founded in 2006.
How many portfolio companies does 683 Capital Management have?
683 Capital Management has 1 portfolio company in Caplight's dataset.
What are some companies in 683 Capital Management's portfolio?
Portfolio companies visible on Caplight include Amylyx Pharmaceuticals.
What was 683 Capital Management's most recent investment shown here?
683 Capital Management's most recent investment in this portfolio sample was in Amylyx Pharmaceuticals in 2021.
What sectors does 683 Capital Management focus on?
683 Capital Management focuses on Healthcare & Life Sciences.
What company stages does 683 Capital Management focus on?
683 Capital Management typically invests at the Mid stage.
What is 683 Capital Management's AUM?
683 Capital Management's assets under management are estimated between $2.2B and $2.2B.